Leukocyte glucose index as a novel biomarker for COVID-19 severity

The severity of coronavirus disease 2019 (COVID-19) quickly progresses with unfavorable outcomes due to the host immune response and metabolism alteration. Hence, we hypothesized that leukocyte glucose index (LGI) is a biomarker for severe COVID-19. This study involved 109 patients and the usefulnes...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos-Hernández, Wendy Marilú, Soto, Luis F., Del Rosario-Trinidad, Marcos, Farfan-Morales, Carlos Noe, De Jesús-González, Luis Adrián, Martínez-Mier, Gustavo, Osuna-Ramos, Juan Fidel, Bastida-González, Fernando, Bernal-Dolores, Víctor, del Ángel, Rosa María, Reyes-Ruiz, José Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438363/
https://www.ncbi.nlm.nih.gov/pubmed/36056114
http://dx.doi.org/10.1038/s41598-022-18786-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438363/
https://www.ncbi.nlm.nih.gov/pubmed/36056114
http://dx.doi.org/10.1038/s41598-022-18786-5

Ejemplares similares